Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 10/9/23 → 10/9/25 |
Funding
- Worldwide Clinical Trials: $36,282.00
BIA 28-6156-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson's Disease With a Pathogenic Variant in the Gluc
- Yamasaki, Tritia (PI)